Other Viruses Citation List: April 13 - April 26, 2012

Hepatitis B virus

1. Synthesis, Biological Evaluation and Structure-Activity Relationships of Glycyrrhetinic acid Derivatives as Novel anti-Hepatitis B Virus Agents. Wang, L.J., C.A. Geng, Y.B. Ma, X.Y. Huang, J. Luo, H. Chen, X.M. Zhang, and J.J. Chen, Bioorganic & Medicinal Chemistry Letters, 2012. [Epub ahead of print]; PMID[22520261].
[PubMed]. OV_0413-042612.

Hepatitis C Virus

2. Isoflavone Agonists of IRF-3 Dependent Signaling have Antiviral Activity against RNA Viruses. Bedard, K.M., M.L. Wang, S.C. Proll, Y.M. Loo, M.G. Katze, M. Gale, Jr., and S.P. Iadonato, Journal of Virology, 2012. [Epub ahead of print]; PMID[22532686].
[PubMed]. OV_0413-042612.

3. Synthesis, in Vitro and in Silico NS5B Polymerase Inhibitory Activity of Benzimidazole Derivatives. Patil, V.M., K.R. Gurukumar, M. Chudayeu, S.P. Gupta, S. Samanta, N. Masand, and N. Kaushik-Basu, Medicinal Chemistry (Shariqah (United Arab Emirates)), 2012. [Epub ahead of print]; PMID[22530910].
[PubMed]. OV_0413-042612.

6. 5-Acetyl-2-arylbenzimidazoles as Antiviral Agents. Part 4. Vitale, G., P. Corona, M. Loriga, A. Carta, G. Paglietti, G. Giliberti, G. Sanna, P. Farci, M.E. Marongiu, and P. La Colla, European Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22513121].
[PubMed]. OV_0413-042612.

7. In Vitro and ex Vivo Delivery of Short Hairpin RNAs for Control of Hepatitis C Viral Transcript Expression. Lonze, B.E., H.T. Holzer, M.K. Knabel, J.E. Locke, G.A. Dicamillo, S.S. Karhadkar, R.A. Montgomery, Z. Sun, D.S. Warren, and A.M. Cameron, Archives of Surgery (Chicago, Ill. : 1960), 2012. 147(4): p. 384-387; PMID[22508787].
[PubMed]. OV_0413-042612.

8. Synthesis and Biological Evaluation of New Potent and Selective HCV NS5A Inhibitors. Shi, J., L. Zhou, F. Amblard, D.R. Bobeck, H. Zhang, P. Liu, L. Bondada, T.R. McBrayer, P.M. Tharnish, T. Whitaker, S.J. Coats, and R.F. Schinazi, Bioorganic and Medicinal Chemistry Letters, 2012. [Epub ahead of print]; PMID[22507961].
[PubMed]. OV_0413-042612.

9. Anti-hepatitis C Virus Activity of 3-Hydroxy Caruilignan C from Swietenia macrophylla Stems. Wu, S.F., C.K. Lin, Y.S. Chuang, F.R. Chang, C.K. Tseng, Y.C. Wu, and J.C. Lee, Journal of Viral Hepatitis, 2012. 19(5): p. 364-370; PMID[22497816].
[PubMed]. OV_0413-042612.

Epstein-Barr Virus

10. Anti-tumour Promoting Activity and Antioxidant Properties of Girinimbine Isolated from the Stem Bark of Murraya koenigii S. Kok, Y.Y., L.Y. Mooi, K. Ahmad, M.A. Sukari, N. Mat, M. Rahmani, and A.M. Ali, Molecules (Basel, Switzerland), 2012. 17(4): p. 4651-4660; PMID[22522395].
[PubMed]. OV_0413-042612.

HSV-1

11. Diastereoselective Multicomponent Synthesis and anti-HSV-1 Evaluation of Dihydrofuran-fused Derivatives. Scala, A., M. Cordaro, F. Risitano, I. Colao, A. Venuti, M.T. Sciortino, P. Primerano, and G. Grassi, Molecular Diversity, 2012. [Epub ahead of print]; PMID[22528269].
[PubMed]. OV_0413-042612.

12. The Anti-herpetic Activity of Trichosanthin via the Nuclear Factor-kappaB and p53 Pathways. He, D., Y. Zheng, and S. Tam, Life Sciences, 2012. [Epub ahead of print]; PMID[22498878].
[PubMed]. OV_0413-042612.

HSV-2

13. Identification of OASL d, a Splice Variant of Human OASL, with Antiviral Activity. Guo, X., X. Li, Y. Xu, T. Sun, G. Yang, Z. Wu, and E. Li, The International Journal of Biochemistry & Cell Biology, 2012. [Epub ahead of print]; PMID[22531715].
[PubMed]. OV_0413-042612.

Citations from the ISI Web of Knowledge Listings for O.V.

14. Antihepatitis B Virus Constituents of Solanum erianthum. Chou, S.C., T.J. Huang, E.H. Lin, C.H. Huang, and C.H. Chou, Natural Product Communications, 2012. 7(2): p. 153-156; ISI[000300817600005].
[WOS]. OV_0413-042612.

15. Reducing Agents Affect Inhibitory Activities of Compounds: Results from Multiple Drug Targets. Lee, H., J. Torres, L. Truong, R. Chaudhuri, A. Mittal, and M.E. Johnson, Analytical Biochemistry, 2012. 423(1): p. 46-53; ISI[000301759200008].
[WOS]. OV_0413-042612.

16. Discovery of GS-9451: An Acid Inhibitor of the Hepatitis C Virus NS3/4A Protease. Sheng, X.C., T. Appleby, T. Butler, R.B. Cai, X.W. Chen, A.S. Cho, M.O. Clarke, J. Cottell, W.E. Delaney, E. Doerffler, J. Link, M.Z. Ji, R. Pakdaman, H.J. Pyun, Q.Y. Wu, J. Xu, and C.U. Kim, Bioorganic & Medicinal Chemistry Letters, 2012. 22(7): p. 2629-2634; ISI[000301846100053].
[WOS]. OV_0413-042612.